88 related articles for article (PubMed ID: 8754393)
1. [The expression of c-myc protein in uterine cervical cancer: a possible prognostic indicator].
Wu HJ
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):515-21. PubMed ID: 8754393
[TBL] [Abstract][Full Text] [Related]
2. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
Tanimoto H; Nagai N; Fujimoto H; Ohta S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):566-70. PubMed ID: 1619315
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
4. Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma.
Yu Y; Dong W; Li X; Yu E; Zhou X; Li S
Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1322-6. PubMed ID: 14676159
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
[TBL] [Abstract][Full Text] [Related]
6. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
Riou GF; Bourhis J; Le MG
Anticancer Res; 1990; 10(5A):1225-31. PubMed ID: 2173473
[TBL] [Abstract][Full Text] [Related]
7. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
8. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
9. Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.
Yeasmin S; Nakayama K; Ishibashi M; Katagiri A; Iida K; Purwana IN; Nakayama N; Miyazaki K
Clin Cancer Res; 2008 Mar; 14(6):1686-91. PubMed ID: 18347169
[TBL] [Abstract][Full Text] [Related]
10. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
11. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
15. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
Gadducci A; Tana R; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
[TBL] [Abstract][Full Text] [Related]
16. Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer.
Liao LM; Sun XY; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M; Huang L
Gynecol Oncol; 2014 Jun; 133(3):616-23. PubMed ID: 24667250
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.
Hawksworth D; Ravindranath L; Chen Y; Furusato B; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):311-5. PubMed ID: 20820186
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
19. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen.
Obermair A; Wanner C; Bilgi S; Speiser P; Reisenberger K; Kaider A; Kainz C; Leodolter S; Breitenecker G; Gitsch G
Cancer; 1998 Feb; 82(4):689-96. PubMed ID: 9477101
[TBL] [Abstract][Full Text] [Related]
20. Relationship of p53 alteration and myc family gene overexpression with the clinical characteristics of lung cancer.
Bai L; Sun Y; Li S
Chin Med J (Engl); 1997 Apr; 110(4):250-4. PubMed ID: 9594222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
